Prothena | PRTA - EPS Earnings Per Share

Stock Price
10.01
Daily Change
0.15 1.52%
Monthly
2.04%
Yearly
-7.66%
Q2 Forecast
9.55

Prothena reported $-0.46 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 -0.35 -1.12 May/13




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Akebia Therapeutics USD -0.04 0.04 Dec/2025
ALKERMES USD 0.29 0.2 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Exelixis USD 0.97 0.19 Dec/2025
Immunic USD -0.24 0.03 Sep/2024
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Prothena USD -0.46 0.22 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025
Xoma USD -1.59 2.43 Sep/2024